📖

depression

active

wiki page Created: 2026-04-02T11:21:26 By: import Quality: 70% ✓ SciDEX ID: wiki-depression

Related Entities

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

75

Outgoing

94

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (94)

related🧫Stress-induced depression model sleep architecture analysis70%

related🧫Pathway analysis of aminophylline effects on neuronal signal70%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson70%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr70%

related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne70%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%

related🧫Bmal1 knockout in mPFC excitatory neurons70%

related🧫Alpha-Synuclein Seed Amplification Assay Validation70%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa70%

related🧫REV-ERB pharmacological activation blocks SD effects70%

related🧫Combination Therapy Sequencing in Parkinson's Disease70%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio70%

related🧫Cytochrome Therapeutics70%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 70%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas70%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation70%

related🧫Prodromal Parkinson's Disease Biomarker Development — E70%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back70%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation70%

related🧫Dexamethasone treatment study in α-synuclein mice70%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera70%

related🧫Computational Modeling of Alpha-Synuclein Propagation in PD70%

related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown70%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%

related🧫Experiment: Multi-Ethnic PD GWAS70%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%

related🧫C1q neutralizing antibody intervention in depression model70%

related🧫Circadian gene expression effects of SD vs ketamine70%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD70%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design70%

related🧫TLR expression in α-synuclein overexpressing mice70%

related🧫MLCS Quantification in Parkinson's Disease70%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D70%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P70%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🧫LPS-induced mouse model of depression with synaptic loss ana70%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim70%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&70%

related🧫Parkinson's Disease Subtype Classification — Precision 70%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease70%

related🧫Validation: Membrane-Nucleation in iPSC Neurons70%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%

related🧫AAV-LRRK2 IND-Enabling Study Design70%

related🧫Longitudinal TLR2 reporter gene study in α-synuclein mice70%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#70%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%

related🧫iPSC-derived astrocyte-neuron co-culture mitochondrial trans70%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD70%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD70%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&70%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper70%

related🧫Ferroptosis Validation in Parkinson's Disease70%

related🧫Molecular docking analysis of aminophylline binding targets70%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin70%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me70%

related🧫Antidepressant effects of aminophylline in chronic restraint70%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%

related🧫TLR expression analysis in Parkinson's disease patients70%

related🧫Antiviral Therapy Trial for Parkinson's Disease70%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%

related🧫CRISPR Gene Correction Approaches for CBS/PSP70%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea70%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 70%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

mentions🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste50%

mentions🧪Flotillin-1 Stabilization Compounds50%

mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying sleep disruption as cause50%

mentions🧪Orexin-Microglia Modulation Therapy50%

mentions🧪Purinergic Signaling Polarization Control50%

mentions🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%

mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%

mentions🧪Retinal Vascular Microcirculation Rescue50%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro40%

related🧪SASP-Mediated Complement Cascade Amplification40%

💬 Discussion